ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VXRT Vaxart Inc

0.8897
-0.1037 (-10.44%)
Last Updated: 14:02:51
Delayed by 15 minutes

Period:

Draw Mode:

Volume 845,653
Bid Price 0.8869
Ask Price 0.8924
News -
Day High 0.99

Low
0.53

52 Week Range

High
1.54

Day Low 0.8801
Share Name Share Symbol Market Stock Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.1037 -10.44% 0.8897 14:02:51
Open Price Low Price High Price Close Price Previous Close
0.99 0.8801 0.99 0.9934
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,384 845,653 US$ 0.9315069 US$ 787,732 - 0.53 - 1.54
Last Trade Type Quantity Price Currency
14:03:39 1 US$ 0.89 USD

Vaxart Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
154.74M 173.86M - 7.38M -82.47M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vaxart News

Date Time Source News Article
5/13/202415:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:03Edgar (US Regulatory)Form 8-K - Current report
5/13/202415:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports First Quarter..
5/13/202406:10IH Market NewsU.S. Futures Climb Amid High Expectations for Inflation..
5/07/202407:00GlobeNewswire Inc.Vaxart to Host First Quarter 2024 Business Update and..
4/30/202407:00GlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus..
3/27/202407:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024..
3/20/202407:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
3/14/202415:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023..
3/14/202406:41IH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil..
3/07/202407:00GlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial..
3/06/202408:23Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VXRT Message Board. Create One! See More Posts on VXRT Message Board See More Message Board Posts

Historical VXRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.99991.060.84310.96896811,828,867-0.1102-11.02%
1 Month0.701.060.63310.82449191,592,8120.189727.10%
3 Months1.291.410.63311.011,604,749-0.4003-31.03%
6 Months0.711.540.530.98185311,643,7000.179725.31%
1 Year1.411.540.530.91858661,518,451-0.5203-36.90%
3 Years6.748710.330.534.692,978,046-5.86-86.82%
5 Years0.7124.900.25436.716,452,6030.179725.31%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.